Get started
Ventyx Biosciences, Inc.Ventyx Biosciences, Inc.Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

VTYX trade ideas

Strong Buy!Im a buyer of this stock..Im long Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that a late-breaking abstract including new long-term extension (LTE) data from the Phase 2 trial of tamuzimod in ulcerative colitis was presented on October 15, 2024 during the United European Gastroenterology (UEG) Week meeting in Vienna, Austria. We are excited to present the new long-term extension data from the tamuzimod Phase 2 trial in patients with ulcerative colitis at UEG Week,” said Raju Mohan, PhD, Chief Executive Officer. “These 52-week data continue to reinforce the potential best-in-class profile of our S1P1R modulator tamuzimod in ulcerative colitis, with a potential best-in-disease safety profile amongst all the oral options for UC therapy. We believe the high rates of clinical remission and endoscopic remission position tamuzimod as the backbone of future combination therapies for UC.”
NASDAQ:VTYXLong
by sebastiannatalia
VTYX- a risky biotechnology penny stock LONGVTRX is on a 120 minute chart, currently trading at 90% off its ATH and 50% above its absolute long term support level. Price tried to cross above the long term mean VWAP 3 months ago but was rejected. I anticipate that in time it will try to so so again. From 3.3 to a target of 9 would be a move in the neighborhood of 300%. I will take a small position long trade here. This will be highly volatile. I will place a 25% stop loss to give VTRX room to roam for a couple of earnings periods. Once the price rises 25% I will convert to a trailing stop loss of 25% and make the then risk free trade low maintenance.
NASDAQ:VTYXLong
by AwesomeAvani
VTYX- Buy the Pullback after a massive Bullish Surge LONGVTYX is an illustrative case in the trend is your friend. VTTX warmed up on Frbruary 20th and went parabolic on the next day and then faded while the moving averages and VWAP lines caught up. This is a buyable dip. It has now printed a couple of engulfing bullish candles. VTYX did less than a full 0.5 retracement as a sign of strength. I will take a long trade here targeting 16% upside to the top pivot of the recent price action. If the price can reach the target I will take half screening for higher-than-normal volatility. At present the volatility has mildly popped over the running mean telling me the continuation is on the ready. The plus here is earnings will report on March 24th so there is one month for traders to run the price up on this stock in that anticipation. Options are avaiable for call contracts expiring March 15th.
NASDAQ:VTYXLong
by AwesomeAvani
VTYX falls to support on private offering Biotech LONGVTYX- Ventyx Biosciences, Inc. (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, announced today that it has entered into a stock purchase agreement for the sale of 11,174,000 shares of its common stock at an offering price of $8.95 per share in a private placement to certain qualified institutional buyers in a bearish news catalyst on March 7th. I have recently uploaded my idea for VTYX on February 27th. Any traders who bought at 7.00 based on that idea may have sold on March 6th for 11.00 and achieved a 55% return in less than two weeks. On the 15 minute chart, VTYX has pulled back to support from the news catalyst. It has settled on the first upper VWAP band where it also found support in February after the post-earnings bullrun and again on February 27th when I uploaded the prior idea. VTYX is now at the bottom of a megaphone pattern ( broadening wedge) reflecting increasing volatility. The predictive algorithm from Lux Algo shows a forecast consistent with price action about the confluence of the support trendline in green and the first upper VWAP band in thick blue while the regression line and then predictive algorithm derived from it is the black line. Biotechnology especially small caps are among the hottest sectors at this time. This one went from cold to very hot and is now lukewarm while readying another bout of bullish momentum. I will revest capital from the previous 10 day trade in a long position expectant of a target of 11 or about 35-40% upside from current price.
NASDAQ:VTYXLong
by AwesomeAvani
VTYX - long - catalysts and gap - amazing R/RVentyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Its lead product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors. This is not a financial advice! Recent block buy Upcoming catalyst end of March 2024 Low float of 44.47M Short float 11.20% Keep an eye on 2.80 level - needs to get broken for a further upmove. SL under 1.8 Potenential gap fill: TP approx. 14 -15 Most info on the chart. Trade carefully!
NASDAQ:VTYXLong
by meitshels_smell_trades
$VTYX is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea The share price is rising and gonna continue this trend today. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price today. So I opened a long position from $19,95; stop-loss — $18,49; take-profit — $24,33/MOC price. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas.
NASDAQ:VTYXLong
by KozakHlib